279 related articles for article (PubMed ID: 31039129)
41. ALS/FTD mutations in UBQLN2 impede autophagy by reducing autophagosome acidification through loss of function.
Wu JJ; Cai A; Greenslade JE; Higgins NR; Fan C; Le NTT; Tatman M; Whiteley AM; Prado MA; Dieriks BV; Curtis MA; Shaw CE; Siddique T; Faull RLM; Scotter EL; Finley D; Monteiro MJ
Proc Natl Acad Sci U S A; 2020 Jun; 117(26):15230-15241. PubMed ID: 32513711
[TBL] [Abstract][Full Text] [Related]
42. Systemic overexpression of SQSTM1/p62 accelerates disease onset in a SOD1
Mitsui S; Otomo A; Nozaki M; Ono S; Sato K; Shirakawa R; Adachi H; Aoki M; Sobue G; Shang HF; Hadano S
Mol Brain; 2018 May; 11(1):30. PubMed ID: 29843805
[TBL] [Abstract][Full Text] [Related]
43. Clinical features of TBK1 carriers compared with C9orf72, GRN and non-mutation carriers in a Belgian cohort.
Van Mossevelde S; van der Zee J; Gijselinck I; Engelborghs S; Sieben A; Van Langenhove T; De Bleecker J; Baets J; Vandenbulcke M; Van Laere K; Ceyssens S; Van den Broeck M; Peeters K; Mattheijssens M; Cras P; Vandenberghe R; De Jonghe P; Martin JJ; De Deyn PP; Cruts M; Van Broeckhoven C;
Brain; 2016 Feb; 139(Pt 2):452-67. PubMed ID: 26674655
[TBL] [Abstract][Full Text] [Related]
44. In-vivo genetic ablation of metabotropic glutamate receptor type 5 slows down disease progression in the SOD1
Bonifacino T; Provenzano F; Gallia E; Ravera S; Torazza C; Bossi S; Ferrando S; Puliti A; Van Den Bosch L; Bonanno G; Milanese M
Neurobiol Dis; 2019 Sep; 129():79-92. PubMed ID: 31102766
[TBL] [Abstract][Full Text] [Related]
45. The ALS-FTD-linked gene product, C9orf72, regulates neuronal morphogenesis via autophagy.
Ho WY; Tai YK; Chang JC; Liang J; Tyan SH; Chen S; Guan JL; Zhou H; Shen HM; Koo E; Ling SC
Autophagy; 2019 May; 15(5):827-842. PubMed ID: 30669939
[TBL] [Abstract][Full Text] [Related]
46. A novel
Lamb R; Rohrer JD; Real R; Lubbe SJ; Waite AJ; Blake DJ; Walters RJ; Lashley T; Revesz T; Holton JL; Morris HR
Cold Spring Harb Mol Case Stud; 2019 Jun; 5(3):. PubMed ID: 31160356
[TBL] [Abstract][Full Text] [Related]
47. Distinct roles for motor neuron autophagy early and late in the SOD1
Rudnick ND; Griffey CJ; Guarnieri P; Gerbino V; Wang X; Piersaint JA; Tapia JC; Rich MM; Maniatis T
Proc Natl Acad Sci U S A; 2017 Sep; 114(39):E8294-E8303. PubMed ID: 28904095
[TBL] [Abstract][Full Text] [Related]
48. TBK1 haploinsufficiency in ALS and FTD compromises membrane trafficking.
Lu Y; Almeida S; Gao FB
Acta Neuropathol; 2021 Jul; 142(1):217-221. PubMed ID: 34081168
[No Abstract] [Full Text] [Related]
49. Beyond ALS and FTD: the phenotypic spectrum of TBK1 mutations includes PSP-like and cerebellar phenotypes.
Wilke C; Baets J; De Bleecker JL; Deconinck T; Biskup S; Hayer SN; Züchner S; Schüle R; De Jonghe P; Synofzik M
Neurobiol Aging; 2018 Feb; 62():244.e9-244.e13. PubMed ID: 29137817
[TBL] [Abstract][Full Text] [Related]
50. The converging roles of sequestosome-1/p62 in the molecular pathways of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD).
Davidson JM; Chung RS; Lee A
Neurobiol Dis; 2022 May; 166():105653. PubMed ID: 35143965
[TBL] [Abstract][Full Text] [Related]
51. UBQLN2/P62 cellular recycling pathways in amyotrophic lateral sclerosis and frontotemporal dementia.
Fecto F; Siddique T
Muscle Nerve; 2012 Feb; 45(2):157-62. PubMed ID: 22246868
[TBL] [Abstract][Full Text] [Related]
52. Pathogenic role of BECN1/Beclin 1 in the development of amyotrophic lateral sclerosis.
Nassif M; Valenzuela V; Rojas-Rivera D; Vidal R; Matus S; Castillo K; Fuentealba Y; Kroemer G; Levine B; Hetz C
Autophagy; 2014 Jul; 10(7):1256-71. PubMed ID: 24905722
[TBL] [Abstract][Full Text] [Related]
53. TBK1 variants in Chinese patients with amyotrophic lateral sclerosis: Genetic analysis and clinical features.
Zhao B; Jiang Q; Lin J; Wei Q; Li C; Hou Y; Cao B; Zhang L; Ou R; Liu K; Yang T; Xiao Y; Shang H
Eur J Neurol; 2023 Oct; 30(10):3079-3089. PubMed ID: 37422901
[TBL] [Abstract][Full Text] [Related]
54. Implications of Microglia in Amyotrophic Lateral Sclerosis and Frontotemporal Dementia.
Haukedal H; Freude K
J Mol Biol; 2019 Apr; 431(9):1818-1829. PubMed ID: 30763568
[TBL] [Abstract][Full Text] [Related]
55. Knocking down metabotropic glutamate receptor 1 improves survival and disease progression in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis.
Milanese M; Giribaldi F; Melone M; Bonifacino T; Musante I; Carminati E; Rossi PI; Vergani L; Voci A; Conti F; Puliti A; Bonanno G
Neurobiol Dis; 2014 Apr; 64():48-59. PubMed ID: 24361555
[TBL] [Abstract][Full Text] [Related]
56. Synaptic dysfunction and altered excitability in C9ORF72 ALS/FTD.
Starr A; Sattler R
Brain Res; 2018 Aug; 1693(Pt A):98-108. PubMed ID: 29453960
[TBL] [Abstract][Full Text] [Related]
57. A glaucoma- and ALS-associated mutant of OPTN induces neuronal cell death dependent on Tbk1 activity, autophagy and ER stress.
Medchalmi S; Tare P; Sayyad Z; Swarup G
FEBS J; 2021 Aug; 288(15):4576-4595. PubMed ID: 33548116
[TBL] [Abstract][Full Text] [Related]
58. Aggregates of mutant protein appear progressively in dendrites, in periaxonal processes of oligodendrocytes, and in neuronal and astrocytic perikarya of mice expressing the SOD1(G93A) mutation of familial amyotrophic lateral sclerosis.
Stieber A; Gonatas JO; Gonatas NK
J Neurol Sci; 2000 Aug; 177(2):114-23. PubMed ID: 10980307
[TBL] [Abstract][Full Text] [Related]
59. In-vivo effects of knocking-down metabotropic glutamate receptor 5 in the SOD1
Bonifacino T; Cattaneo L; Gallia E; Puliti A; Melone M; Provenzano F; Bossi S; Musante I; Usai C; Conti F; Bonanno G; Milanese M
Neuropharmacology; 2017 Sep; 123():433-445. PubMed ID: 28645622
[TBL] [Abstract][Full Text] [Related]
60. Pathological Modification of TDP-43 in Amyotrophic Lateral Sclerosis with SOD1 Mutations.
Jeon GS; Shim YM; Lee DY; Kim JS; Kang M; Ahn SH; Shin JY; Geum D; Hong YH; Sung JJ
Mol Neurobiol; 2019 Mar; 56(3):2007-2021. PubMed ID: 29982983
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
